Harvey Branton, senior translational consultant at cell and gene therapy CDMO eXmoor Pharma, shares insights into early process development, exploring common misconceptions that could impact long-term manufacturing success for ATMP developers.
Harvey Branton, senior translational consultant at cell and gene therapy CDMO eXmoor Pharma, shares invaluable insights into early process development, exploring common misconceptions that could impact long-term manufacturing success for ATMP developers.
eXmoor
The week's biggest stories from this industry, direct to your inbox.
